Report cover image

Middle East and Africa Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic); By Application (Cancer, Cardiology); By Source (Nuclear Reactors, Cyclotrons); By End Use (Hospitals & Clinics, Medical Imaging Centers); By Country (Saudi Arabia, UAE,

Publisher BlueWeave Consulting
Published Jan 30, 2024
Length 200 Pages
SKU # BLWC18529296

Description

Middle East and Africa Radiopharmaceuticals Market Size Expands at Significant CAGR of 6.01% to Touch USD 0.29 Billion by 2030

Middle East and Africa Radiopharmaceuticals Market is propelled by growing prevalence of chronic diseases, an increasing demand for nuclear medicine procedures, rising investments in healthcare infrastructure, and expanding applications.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa Radiopharmaceuticals Market size at USD 0.21 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Middle East and Africa Radiopharmaceuticals Market size to grow at a CAGR of 6.01% reaching a value of USD 0.29 billion by 2030. The Middle East and Africa Radiopharmaceuticals Market is driven by the increasing prevalence of chronic diseases, rising adoption of nuclear medicine for diagnosis and treatment, and growing awareness about advanced medical imaging techniques. Additionally, expanding healthcare infrastructure, rising investments in research and development, and supportive government initiatives contribute to market growth. The demand for radiopharmaceuticals is further fueled by the aging population, technological advancements in nuclear medicine, and the rising incidence of cancer. These factors collectively enhance the diagnostic and therapeutic capabilities of radiopharmaceuticals, fostering market expansion in the Middle East and Africa.

Opportunity – Innovative nuclear medicine breakthroughs

The advancements of nuclear medicine technologies in the Middle East and Africa region are driving the Radiopharmaceuticals Market in the region. Pioneering breakthroughs, such as cutting-edge imaging and therapeutic applications, are revolutionizing healthcare practices. The synergy of evolving diagnostic capabilities and targeted treatments is reshaping the medical landscape, propelling the market forward, and ensuring a brighter, more precise future for patient care in the region.

Impact of Escalating Geopolitical Tensions on Middle East and Africa Radiopharmaceuticals Market

Escalating geopolitical tensions in the Middle East and Africa pose significant challenges to the growth of Radiopharmaceuticals Market in the region. Uncertainties in the region disrupt supply chains, hindering the production and distribution of essential radiopharmaceuticals. Increased political instability may also deter foreign investments and collaborations, limiting technological advancements and research initiatives. In such an environment, regulatory frameworks may face delays, impacting market approvals and market entry for innovative products. Additionally, heightened geopolitical risks may lead to fluctuating currency values, affecting pricing strategies and overall market dynamics. The Middle East and Africa Radiopharmaceuticals Market could experience reduced growth and innovations, as geopolitical tensions create an unpredictable and challenging business environment for stakeholders in the industry.

Middle East and Africa Radiopharmaceuticals Market

Segmental Coverage

Middle East and Africa Radiopharmaceuticals Market – By Type

Based on type, Middle East and Africa Radiopharmaceuticals Market is split into Diagnostic and Therapeutic segments. The diagnostic radiopharmaceuticals segment represent a larger segment in the Middle East and Africa Radiopharmaceuticals Market. The substances are extensively used in nuclear medicine procedures for imaging various physiological functions and structures within the body. Diagnostic radiopharmaceuticals aid in the detection and diagnosis of diseases, making them a significant component of medical imaging practices in the Middle East and Africa region. The segment's prominence underscores the pivotal role of radiopharmaceuticals in advancing diagnostic capabilities in the healthcare landscape of the region.

Middle East and Africa Radiopharmaceuticals Market – By Application

By application, Middle East and Africa Radiopharmaceuticals Market is bifurcated into Cancer and Cardiology segments. The cancer segment is a larger segment in the Middle East and Africa Radiopharmaceuticals Market by application. This indicates a significant focus on addressing oncology-related diagnostic and therapeutic needs in the region. The emphasis on cancer-related radiopharmaceuticals underscores the importance of advancing medical solutions for diagnosing and treating various types of cancers, reflecting the healthcare priorities and challenges in the Middle East and Africa. The market's attention to the cancer segment suggests a dedicated effort to enhance cancer care and management in the region through innovative radiopharmaceutical interventions.

Competitive Landscape

Middle East and Africa Radiopharmaceuticals Market is fiercely competitive. Major companies in the market include Siemens AG, GE Healthcare, Curium, Lantheus Holdings Inc., Eckert & Ziegler, and Novartis. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Middle East and Africa Radiopharmaceuticals Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East and Africa Radiopharmaceuticals Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Middle East and Africa Radiopharmaceuticals Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

200 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Middle East and Africa Radiopharmaceuticals Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. The rising demand for personalized medicine
3.1.2.2. The increasing prevalence of chronic diseases
3.1.3. Restraints
3.1.3.1. High Production Costs
3.1.4. Opportunities
3.1.4.1. The advancement of nuclear medicine technologies
3.1.5. Challenges
3.1.5.1. Short Half-life of Radiopharmaceuticals
3.2. Technological Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Middle East and Africa Radiopharmaceuticals Market Overview
4.1. Market Size & Forecast, 2019–2030
4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
4.2.1. By Type
4.2.1.1. Diagnostic
4.2.1.2. Therapeutic
4.2.2. By Application
4.2.2.1. Cancer
4.2.2.2. Cardiology
4.2.2.3. Others
4.2.3. By Source
4.2.3.1. Nuclear Reactors
4.2.3.2. Cyclotrons
4.2.4. By End Use
4.2.4.1. Hospitals and Clinics
4.2.4.2. Medical Imaging Centers
4.2.4.3. Others
4.2.5. By Country
4.2.5.1. Saudi Arabia
4.2.5.2. UAE
4.2.5.3. Qatar
4.2.5.4. Kuwait
4.2.5.5. South Africa
4.2.5.6. Nigeria
4.2.5.7. Algeria
4.2.5.8. Rest of MEA
5. Saudi Arabia Radiopharmaceuticals Market
5.1. Market Size & Forecast, 2019–2030
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Application
5.2.3. By Source
5.2.4. By End Use
6. UAE Radiopharmaceuticals Market
6.1. Market Size & Forecast, 2019–2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Source
6.2.4. By End Use
7. Qatar Radiopharmaceuticals Market
7.1. Market Size & Forecast, 2019–2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Source
7.2.4. By End Use
8. Kuwait Radiopharmaceuticals Market
8.1. Market Size & Forecast, 2019–2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Source
8.2.4. By End Use
9. South Africa Radiopharmaceuticals Market
9.1. Market Size & Forecast, 2019–2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Source
9.2.4. By End Use
10. Nigeria Radiopharmaceuticals Market
10.1. Market Size & Forecast, 2019–2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Source
10.2.4. By End Use
11. Algeria Radiopharmaceuticals Market
11.1. Market Size & Forecast, 2019–2030
11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Application
11.2.3. By Source
11.2.4. By End Use
12. Rest of MEA Radiopharmaceuticals Market
12.1. Market Size & Forecast, 2019–2030
12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By Application
12.2.3. By Source
12.2.4. By End Use
13. Competitive Landscape
13.1. List of Key Players and Their Offerings
13.2. Middle East and Africa Radiopharmaceuticals Company Market Share Analysis, 2023
13.3. Competitive Benchmarking, By Operating Parameters
13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
14. Impact of Escalating Geopolitical Tensions on Middle East and Africa Radiopharmaceuticals Market
15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
15.1. Siemens AG
15.2. GE Healthcare
15.3. Curium
15.4. Lantheus Holdings Inc.
15.5. Eckert & Ziegler
15.6. Novartis
15.7. Other Prominent Players
16. Key Strategic Recommendations
17. Research Methodology
17.1. Qualitative Research
17.1.1. Primary & Secondary Research
17.2. Quantitative Research
17.3. Market Breakdown & Data Triangulation
17.3.1. Secondary Research
17.3.2. Primary Research
17.4. Breakdown of Primary Research Respondents, By Country
17.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Middle East and Africa Radiopharmaceuticals Market Segmentation
Figure 2 Middle East and Africa Radiopharmaceuticals Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Middle East and Africa Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 5 Middle East and Africa Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 6 Middle East and Africa Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 7 Middle East and Africa Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 8 Middle East and Africa Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 9 Middle East and Africa Radiopharmaceuticals Market Share, By Country, By Value, 2019–2030
Figure 10 Saudi Arabia Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 11 Saudi Arabia Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 12 Saudi Arabia Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 13 Saudi Arabia Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 14 Saudi Arabia Radiopharmaceuticals Market Share, By Distribution Source, By Value, 2019–2030
Figure 15 UAE Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 16 UAE Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 17 UAE Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 18 UAE Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 19 UAE Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 20 Qatar Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 21 Qatar Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 22 Qatar Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 23 Qatar Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 24 Qatar Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 25 Kuwait Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 26 Kuwait Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 27 Kuwait Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 28 Kuwait Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 29 Kuwait Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 30 South Africa Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 31 South Africa Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 32 South Africa Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 33 South Africa Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 34 South Africa Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 35 Nigeria Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 36 Nigeria Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 37 Nigeria Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 38 Nigeria Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 39 Nigeria Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 40 Algeria Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 41 Algeria Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 42 Algeria Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 43 Algeria Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 44 Algeria Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
Figure 45 Rest of MEA Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Figure 46 Rest of MEA Radiopharmaceuticals Market Share, By Type, By Value, 2019–2030
Figure 47 Rest of MEA Radiopharmaceuticals Market Share, By Application, By Value, 2019–2030
Figure 48 Rest of MEA Radiopharmaceuticals Market Share, By Source, By Value, 2019–2030
Figure 49 Rest of MEA Radiopharmaceuticals Market Share, By End Use, By Value, 2019–2030
List of Tables
Table 1 Middle East and Africa Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 2 Middle East and Africa Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 3 Middle East and Africa Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 4 Middle East and Africa Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 5 Middle East and Africa Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 6 Middle East and Africa Radiopharmaceuticals Market Size, By Country, By Value, 2019–2030
Table 7 Saudi Arabia Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 8 Saudi Arabia Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 9 Saudi Arabia Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 10 Saudi Arabia Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 11 Saudi Arabia Radiopharmaceuticals Market Size, By Distribution Source, By Value, 2019–2030
Table 12 UAE Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 13 UAE Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 14 UAE Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 15 UAE Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 16 UAE Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 17 Qatar Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 18 Qatar Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 19 Qatar Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 20 Qatar Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 21 Qatar Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 22 Kuwait Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 23 Kuwait Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 24 Kuwait Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 25 Kuwait Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 26 Kuwait Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 27 South Africa Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 28 South Africa Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 29 South Africa Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 30 South Africa Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 31 South Africa Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 32 Nigeria Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 33 Nigeria Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 34 Nigeria Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 35 Nigeria Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 36 Nigeria Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 37 Algeria Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 38 Algeria Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 39 Algeria Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 40 Algeria Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 41 Algeria Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 42 Rest of MEA Radiopharmaceuticals Market Size, By Value (USD Billion), 2019–2030
Table 43 Rest of MEA Radiopharmaceuticals Market Size, By Type, By Value, 2019–2030
Table 44 Rest of MEA Radiopharmaceuticals Market Size, By Application, By Value, 2019–2030
Table 45 Rest of MEA Radiopharmaceuticals Market Size, By Source, By Value, 2019–2030
Table 46 Rest of MEA Radiopharmaceuticals Market Size, By End Use, By Value, 2019–2030
Table 47 Siemens AG Company Overview
Table 48 Siemens AG Financial Overview
Table 49 GE Healthcare Company Overview
Table 50 GE Healthcare Financial Overview
Table 51 Curium Company Overview
Table 52 Curium Financial Overview
Table 53 Lantheus Holdings Inc. Company Overview
Table 54 Lantheus Holdings Inc. Financial Overview
Table 55 Eckert & Ziegler Company Overview
Table 56 Eckert & Ziegler Financial Overview
Table 57 Novartis Company Overview
Table 58 Novartis Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us